-
Mashup Score: 19Gabriella & Lebella Hanna | A St. Baldrick's Team - 20 day(s) ago
This St. Baldrick’s team has joined together to fight kids’ cancer by shaving their heads and raising money for research! Make a donation to support their efforts, or join the team to be a part of the fun!
Source: www.stbaldricks.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 43Alumni Spotlight: Rabi Hanna - 1 month(s) ago
Rabi Hanna, MD, is chairman of the Pediatric Hematology-Oncology & Bone Marrow Transplantation division at Cleveland Clinic Children’s Hospital. He shares how Duke Pediatrics influenced his global perspective and how more clinical research is imperative to helping children with cancer. Do you think being at Duke gave you a global perspective and/or changed your view on global issues? Duke’s pediatric residency did not train me in pediatrics only; it also influenced me to become a better overall physician
Source: pediatrics.duke.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Understanding the Unique Barriers AYAs with CNS Cancers Face - 2 month(s) ago
In a new systematic review, researchers identify the specific challenges that make it difficult for adolescent and young adults (AYAs) with central nervous system (CNS) cancers to enroll in clinical trials and seek specialized treatment.
Source: www.cancer.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update - 2 month(s) ago
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the number of HCTs perfo…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Announcement - World Cancer Day - CQDM - 3 month(s) ago
On this World Cancer Day, CQDM is proud to contribute to the fight against this global scourge by announcing the funding of three R&D projects made possible thanks to a grant from the Government of Québec of more than $2.4 million.
Source: cqdm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Understanding the Unique Barriers AYAs with CNS Cancers Face - 3 month(s) ago
In a new systematic review, researchers identify the specific challenges that make it difficult for adolescent and young adults (AYAs) with central nervous system (CNS) cancers to enroll in clinical trials and seek specialized treatment.
Source: www.cancer.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group - 4 month(s) ago
PURPOSE Patients with Down syndrome (DS) and B-ALL experience increased rates of relapse, toxicity, and death. We report results for patients with DS B-ALL enrolled on Children’s Oncology Group trials between 2003 and 2019. METHODS We analyzed data for DS (n = 743) and non-DS (n = 20,067) patients age 1-30 years on four B-ALL standard-risk (SR) and high-risk trials. RESULTS Patients with DS exhibited more frequent minimal residual disease (MRD) ≥0.01% at end induction (30.8% v 21.5%; P < .001). This difference persisted at end consolidation only in National Cancer Institute (NCI) high-risk patients (34.0% v 11.7%; P < .0001). Five-year event-free survival (EFS) and overall survival (OS) were significantly poorer for DS versus non-DS patients overall (EFS, 79.2% ± 1.6% v 87.5% ± 0.3%; P < .0001; OS, 86.8% ± 1.4% v 93.6% ± 0.2%; P < .0001), and within NCI SR and high-risk subgroups. Multivariable Cox regression analysis of the DS cohort for risk factors associated with inferior EFS ident
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10New gene editing treatment at Cleveland Clinic offers hope to those with sickle cell disease - 4 month(s) ago
A new gene editing treatment at the Cleveland Clinic is offering hope to those with sickle cell disease.
Source: www.news5cleveland.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic Children’s, conducted a study on AsCas12a gene editing with EDIT-301 for severe Sickle Cell Disease (SCD) and transfusion-dependent β-thalassemia (TDT). The research aimed to evaluate the efficacy of this appr…
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8
Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic Children’s, conducted a study on AsCas12a gene editing with EDIT-301 for severe Sickle Cell Disease (SCD) and transfusion-dependent β-thalassemia (TDT). The research aimed to evaluate the efficacy of this appr…
Source: oncologytube.comCategories: General Medicine News, Hem/OncsTweet
So proud to have my twin girls having their hair cut to support childhood cancer research with @StBaldricks. https://t.co/eNVzBx1HFt